Comercial Visitador Medico

FAES FARMA is a Spanish company with a global focus that researches, produces and markets pharmaceutical products and raw materials. It exports to more than 60 countries. FAES FARMA aims for maximum pharmacological quality in its products, which translates into effective solutions for patients. With the head office in Madrid; Faes Farma has his R&D centre in Bilbao, the Vitoria laboratory in Lisbon with production plants in both cities, and the animal nutrition and health company INGASO FARM. FAES FARMA has 2 subsidiaries and another 3 sales offices abroad, with presence in 45 countries and employing more than 800 persons. Investigation, with Hidrosmin (Venosmil) as the most characteristic molecule of previous investigative efforts, and Bilastine, a new, 2nd generation, non-sedating antihistamine marketed in Spain in 2011, representing the intensive investment in R&D during the last decade, a molecule which totals close to 3 million units since it was launched locally via its 3 trademarks, i.e. Bilaxten (Faes Farma), Ibis (Menarini) and Obalix (GSK). Bilastina is currently marketed in Europe and Latin America and is in clinical and pre-registration phases in Asia and Africa.